United States (USA) (US)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

EWSR1::POU2AF3(COLCA2) Sarcoma: An Aggressive, Polyphenotypic Sarcoma With a Head and Neck Predilection. (2023) Koshyk O, Dehner CA, van den Hout MF, Bempt IV, Sciot R, Huang HY, Agaimy A, et al. Journal article Association between expectations and clinical outcomes in online v. face-to-face therapy - an individual participant data meta-analysis (2023) Pontén M, Jonsjö M, Vadenmark V, Moberg E, Grannas D, Andersson G, Boersma K, et al. Journal article Reconfiguration and loss of peritubular capillaries in chronic kidney disease. (2023) Gaupp C, Schmid B, Tripal P, Edwards A, Daniel C, Zimmermann S, Goppelt-Strübe M, et al. Journal article Empagliflozin in Patients with Chronic Kidney Disease. (2023) Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, et al. Journal article Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production (2023) Perrault EN, Shireman JM, Ali ES, Lin P, Preddy I, Park C, Budhiraja S, et al. Journal article De novo variants in CNOT9 cause a neurodevelopmental disorder with or without epilepsy. (2023) von Wintzingerode L, Ben-Zeev B, Cesario C, Chan KM, Depienne C, Elpeleg O, Iascone M, et al. Journal article Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study. (2023) Hoertel N, Rezaei K, Sánchez-Rico M, Delgado-Álvarez A, Kornhuber J, Gulbins E, Olfson M, et al. Journal article Tominersen in Adults with Manifest Huntington's Disease. (2023) McColgan P, Thobhani A, Boak L, Schobel SA, Nicotra A, Palermo G, Trundell D, et al. Journal article, Letter Advances in osteoarthritis imaging. (2023) Chalian M, Roemer F, Guermazi A Journal article, Review article Corrigendum to Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2- early breast cancer. (2023) Slamon DJ, Fasching P, Hurvitz S Journal article, Erratum